A team of leading Australian and New Zealand health researchers is undertaking a study to pilot a positive lifestyle intervention in New Zealand women. This aims to improve health and wellness in younger women after treatment for cancer.
Most of us are familiar with Herceptin – the medicine that transformed the treatment of HER2-positive breast cancer in the early 2000s. Herceptin is the brand name for this drug which is supplied by pharmaceutical company Roche. Trastuzumab is its generic name.
The Advanced Breast Cancer Global Alliance, of which BCAC is a member, has joined with other international cancer groups to call for a global plan of action for cancer to meet the challenges of COVID-19 and future pandemics or health crises...
Breast surgeon Dr Eva Juhasz has recently finished a study of the current treatment of elderly breast cancer patients in Waitematā DHB.
We have received excellent information about COVID-19 for women with breast cancer from the Māori Cancer Leadership Group and the Cancer Control Agency, that you will find attached.